Central Appalachian Inter-Professional Pain Education Collaborative

Module Three: Risk Management

Activity Details
  • Credit Amounts:
    • CME: 0.50
    • Other: 0.50
  • Cost: Free
  • Release: Dec 6, 2019
  • Expires: Dec 6, 2022
  • Estimated Time to Complete:
    30 Minutes
  • Average User Rating:
    ( Ratings)

Faculty

Roberto Cardarelli Roberto Cardarelli, DO, MPH, FAAFP
Chair and Professor, Family and Community Medicine
University of Kentucky College of Medicine
Lexington, Kentucky

William G.  Elder William G. Elder, PhD
Chair, Behavioral and Social Sciences
University of Houston College of Medicine
Houston, Texas

Needs Statement

The geographic variation throughout Appalachia is poorly understood, creating a tremendous need for regionally sensitive collaborative efforts in professional continuing education with an emphasis on team-based care.

This provides a unique opportunity to transform educational interventions, causing practice change and impacting patient and community outcomes.

CAIPEC’s program intends to impact patient-centered outcomes through advancing knowledge on team-based care and processes and the appropriate management of chronic pain through pharmacologic and non-pharmacologic modalities.

THIS ACTIVITY HAS THE SAME CONTENT AS Module Three: Risk Management THAT EXPIRED ON 8/9/18. IF YOU PARTICIPATED IN THE ORIGINAL ACTIVITY, PLEASE DO NOT COMPLETE THIS RELEASE.

Target Audience

Physicians (MD and DO), advanced practice providers (APP), Nurse Practitioners (NP), Physicians Assistants (PA), Behavioral Scientist (BS) massage and behavioral therapists (MT and BT), and physical therapists (PT)

PTs and PTAs may apply this course toward their Category 2 continued competency activities. When claiming credit, be sure to claim the Participation Credit (Other) to receive a Statement of Participation to use when submitting for the Category 2 continued competency activities.

Objectives

Upon completion of this educational activity, the participant will be able to:

  • Discuss Risk Management including patient factors, tools and resources that can be used and workflows and medication agreements.
  • Identify Non-Pharmacologic and Pharmacologic Treatment Options giving all-encompassing treatment disciplines included in pain management.

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

This training has been approved by the KBML as meeting the statutory requirements of HB1. 0615-H4.5-UK1

ACGME Competencies

  • Patient care

Other
UK Healthcare CECentral certifies this activity for 0.50 hours of participation.

Faculty Disclosure

Roberto Cardarelli, DO, MPH (Planner and Speaker) has relevant financial relationships with commercial interests as follows:
Pfizer, Passport Health, and NIH - Grant/Research Support - Receives salary
Frontier Medicine Better Health Partnership and Montana CMMI Grantee - Consultant - Receives consultant fee

William Elder, PhD (Planner and Speaker) has relevant financial relationships with commercial interests as follows:
Pfizer Foundation, HRSA, and NIH - Grant/Research Support - Receives salary

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

In collaboration with UK Central Appalachia Interprofessional Pain Education Collaborative.